-+ 0.00%
-+ 0.00%
-+ 0.00%

CO-DIAGNOSTICS COMPLETES CLINICAL AND ANALYTICAL STUDIES IN PREPARATION FOR FDA 510(K) SUBMISSION OF UPPER RESPIRATORY POINT-OF-CARE TEST

Reuters·07/01/2026 13:00:10

Please log in to view news